K4 (July 2024)/ CME GLOBEX
K410/07/2024 22:11:48 | Chg. -5.0000 | Bid22:15:02 | Ask22:15:02 | Open | High | Low | Previous Close |
---|---|---|---|---|---|---|---|
500.0000USD | -0.99% | - | - | 500.0000 | 500.0000 | 500.0000 | 505.0000 |
GlobeNewswire
20/09/2019
Roxadustat Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in D...
GlobeNewswire
26/04/2012
Novartis drug Afinitor® approved by FDA as first medication to treat patients with non-cancerous kid...